← Open Payments lookup

RUBY VARKEY: Open Payments

NPI 1851951222 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$872 in 18 payments from 9 companies in 2025. Trend: 2023 $356 · 2024 $810 · 2025 $872

Food & beverage: $835Education: $37
CompanyPaymentsAmount
Astellas Pharma US Inc6$305
PFIZER INC.3$182
SOBI, INC1$115
Syndax Pharmaceuticals, Inc.2$64
JAZZ PHARMACEUTICALS INC.1$60
ABBVIE INC.2$52
Takeda Pharmaceuticals U.S.A., Inc.1$33
Janssen Biotech, Inc.1$32
Incyte Corporation1$28

Products named: Xospata, ELREXFIO, Vonjo, Cresemba, DEFITELIO, EPKINLY, LIVTENCITY, DARZALEX.

Industry payments across TX — which companies pay providers there.